Literature DB >> 18054964

Desensitization of herpesvirus-encoded G protein-coupled receptors.

Joseph D Sherrill1, William E Miller.   

Abstract

Members of the herpesvirus family, including human cytomegalovirus (HCMV) and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8), encode G protein-coupled receptor (GPCR) homologs, which strongly activate classical G protein signal transduction networks within the cell. In animal models of herpesvirus infection, the viral GPCRs appear to play physiologically important roles by enabling viral replication within tropic tissues and by promoting reactivation from latency. While a number of studies have defined intracellular signaling pathways activated by herpesviral GPCRs, it remains unclear if their physiological function is subjected to the process of desensitization as observed for cellular GPCRs. G protein-coupled receptor kinases (GRK) and arrestin proteins have been recently implicated in regulating viral GPCR signaling; however, the role that these desensitization proteins play in viral GPCR function in vivo remains unknown. Here, we review what is currently known regarding viral GPCR desensitization and discuss potential biological ramifications of viral GPCR regulation by the host cell desensitization machinery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054964      PMCID: PMC2239238          DOI: 10.1016/j.lfs.2007.10.024

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  92 in total

1.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity.

Authors:  D E Kuhn; C J Beall; P E Kolattukudy
Journal:  Biochem Biophys Res Commun       Date:  1995-06-06       Impact factor: 3.575

Review 3.  The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution.

Authors:  U A Gompels; J Nicholas; G Lawrence; M Jones; B J Thomson; M E Martin; S Efstathiou; M Craxton; H A Macaulay
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

4.  Determination and analysis of the complete nucleotide sequence of human herpesvirus.

Authors:  J Nicholas
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles.

Authors:  B J Margulies; H Browne; W Gibson
Journal:  Virology       Date:  1996-11-01       Impact factor: 3.616

6.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

7.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

8.  Lipid-mediated regulation of G protein-coupled receptor kinases 2 and 3.

Authors:  S K DebBurman; J Ptasienski; E Boetticher; J W Lomasney; J L Benovic; M M Hosey
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

9.  G protein-coupled receptor kinase GRK2 is a phospholipid-dependent enzyme that can be conditionally activated by G protein betagamma subunits.

Authors:  S K DebBurman; J Ptasienski; J L Benovic; M M Hosey
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

10.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

View more
  6 in total

1.  Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response.

Authors:  Jayme Salsman; Madhav Jagannathan; Patrick Paladino; Pak-Kei Chan; Graham Dellaire; Brian Raught; Lori Frappier
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.

Authors:  Gerold Bongers; Luciana R Muniz; Michelle E Pacer; Alina C Iuga; Nanthakumar Thirunarayanan; Erik Slinger; Martine J Smit; E Premkumar Reddy; Lloyd Mayer; Glaucia C Furtado; Noam Harpaz; Sergio A Lira
Journal:  Gastroenterology       Date:  2012-05-26       Impact factor: 22.682

3.  Activation of intracellular signaling pathways by the murine cytomegalovirus G protein-coupled receptor M33 occurs via PLC-{beta}/PKC-dependent and -independent mechanisms.

Authors:  Joseph D Sherrill; Melissa P Stropes; Olivia D Schneider; Diana E Koch; Fabiola M Bittencourt; Jeanette L C Miller; William E Miller
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

4.  Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor.

Authors:  Berenice Aguilar; Inho Choi; Dongwon Choi; Hee Kyoung Chung; Sunju Lee; Jaehyuk Yoo; Yong Suk Lee; Yong Sun Maeng; Ha Neul Lee; Eunkyung Park; Kyu Eui Kim; Nam Yoon Kim; Jae Myung Baik; Jae U Jung; Chester J Koh; Young-Kwon Hong
Journal:  Cancer Res       Date:  2012-08-31       Impact factor: 12.701

5.  Kaposi's sarcoma-associated herpesvirus-G protein-coupled receptor-expressing endothelial cells exhibit reduced migration and stimulated chemotaxis by chemokine inverse agonists.

Authors:  Jean-Pierre Couty; Monica Lupu-Meiri; Yoram Oron; Marvin C Gershengorn
Journal:  J Pharmacol Exp Ther       Date:  2009-03-03       Impact factor: 4.030

6.  Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity.

Authors:  Hao Feng; Xiaonan Dong; Ashley Negaard; Pinghui Feng
Journal:  PLoS Pathog       Date:  2008-09-19       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.